Source: EURLEX
Language: en
Format: md

|  |  |  |  |
| --- | --- | --- | --- |
| 14.3.2022 | EN | Official Journal of the European Union | C 119/51 |

---

Action brought on 18 January 2022 — Sanoptis v EUIPO — Synoptis Pharma (SANOPTIS)

(Case T-30/22)

(2022/C 119/73)

Language of the case: English

Parties

Applicant: Sanoptis Sàrl (Luxembourg, Luxembourg) (represented by: S. Rost, lawyer)

Defendant: European Union Intellectual Property Office (EUIPO)

Other party to the proceedings before the Board of Appeal: Synoptis Pharma sp. z o.o. (Warsaw, Poland)

Details of the proceedings before EUIPO

Applicant of the trade mark at issue: Applicant before the General Court

Trade mark at issue: Application for European Union word mark SANOPTIS — Application for registration No 17 934 770

Procedure before EUIPO: Opposition proceedings

Contested decision: Decision of the Fourth Board of Appeal of EUIPO of 18 November 2021 in Case R 850/2021-4

Form of order sought

The applicant claims that the Court should:

|  |  |
| --- | --- |
| — | annul the contested decision; |

|  |  |
| --- | --- |
| — | order EUIPO to bear its own costs and to pay those incurred by the applicant; |

|  |  |
| --- | --- |
| — | orders the intervener to bear its own costs. |

Pleas in law

|  |  |
| --- | --- |
| — | Infringement of Article 94(1) of Regulation (EU) 2017/1001 of the European Parliament and of the Council in the failure to state reasons in the contested decision; |

|  |  |
| --- | --- |
| — | Infringement of Article 8(1)(b) of Regulation (EU) 2017/1001 of the European Parliament and of the Council. |

---

[Top](#document1)